The New Jersey Alliance for Clinical and Translational Science (NJ ACTS), NJ’s CTSA, is delighted to announce that it is soliciting applications for its Institutional Career Development (KL2) program. The third class of KL2 Scholars will be appointed starting...
On July 25, 1972, Jean Heller, a reporter on The Associated Press investigative team, then called the Special Assignment Team, broke news that rocked the nation. Based on documents leaked by Peter Buxtun, a whistleblower at the U.S. Public Health Service, the then...
Please read Dr. Gélinas’ article in the Journal of Clinical and Translational Science titled, “The NJ Alliance for Clinical and Translational Science (NJ ACTS) experience: Responding at “warp speed” to COVID-19.” The COVID-19...
According to a recent poll by NPR, the Robert Wood Johnson Foundation and the Harvard T.H. Chan School of Public Health, among households that had a serious illness in the past year, one in five respondents said they had trouble accessing care during the pandemic. ...
A recent National Academies of Sciences, Engineering, and Medicine report details several adverse impacts from poor diversity in clinical trials. These include lack of access to effective medical interventions, compounding of health disparities in underrepresented and...
